Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Dec 27, 2023 (filed on Dec 27, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$46.51
-
Dec 26, 2023 (filed on Dec 27, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$46.00
-
Dec 21, 2023 (filed on Dec 22, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-300,000Price:--
-
Dec 19, 2023 (filed on Dec 20, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$45.14
-
Dec 18, 2023 (filed on Dec 20, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$44.08
-
Dec 14, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:4,277Price:$9.84
-
Dec 14, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Stock Options (right to buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-4,277Price:--
-
Dec 14, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-4,277Price:$44.58
-
Dec 13, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-219Price:$43.61
-
Dec 13, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:219Price:$9.84
Filings by filing date
-
Dec 27, 2023 (filed on Dec 27, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$46.51
-
Dec 26, 2023 (filed on Dec 27, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$46.00
-
Dec 21, 2023 (filed on Dec 22, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:G - Gift# or value acquired/disposed of:-300,000Price:--
-
Dec 19, 2023 (filed on Dec 20, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$45.14
-
Dec 18, 2023 (filed on Dec 20, 2023)Insider Name:Susi Roger E.Ownership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$44.08
-
Dec 14, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:4,277Price:$9.84
-
Dec 13, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-219Price:$43.61
-
Dec 13, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:219Price:$9.84
-
Dec 13, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-5,000Price:$42.80
-
Dec 13, 2023 (filed on Dec 14, 2023)Insider Name:Hawkins James BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:5,000Price:$9.84
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1025 Willa Springs Dr. WINTER SPRINGS FL 32708 |
Tel: | N/A |
Website: | www.iradimed.com |
IR: | See website |
Key People | ||
Roger Susi Chairman of the Board, President, Chief Executive Officer, Founder | John F. Glenn Chief Financial Officer, Corporate Secretary | Randy Waddell Vice President - Worldwide Sales and Marketing |
Steve Kachelmeyer Vice President - Regulatory Affairs and Quality Assurance | Lynn Neuhardt Vice President - Research & Development |
Business Overview |
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient's vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses. |
Financial Overview |
For the fiscal year ended 31 December 2023, Iradimed Corp revenues increased 23% to $65.6M. Net income increased 34% to $17.2M. Revenues reflect United States segment increase of 20% to $52.5M, International segment increase of 39% to $13M. Net income benefited from Interest Income increase from $582K to $1.9M (income), Sales and marketing - Balancing value decrease of 5% to $11.6M (expense). |
Employees: | 148 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $462.70M as of Dec 31, 2023 |
Annual revenue (TTM): | $65.56M as of Dec 31, 2023 |
EBITDA (TTM): | $20.80M as of Dec 31, 2023 |
Net annual income (TTM): | $17.19M as of Dec 31, 2023 |
Free cash flow (TTM): | -$7.77M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 12,662,809 as of Feb 29, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |